DeutschNewstral
Article
The Hindu on 2021-05-28 20:08
Covaxin output cycle may hit Centre’s deadline
Related news
Docs slam ICMR's deadline for launching CovaxinThe Times of India- Slowing down Covaxin output across plants: Bharat BiotechThe Times of India
- Live: Covaxin output set to rise; govt hopes to meet goalThe Times of India
- 1 in 3 Covaxin recipients hit by adverse events: StudyThe Times of India
- Australia recognises CovaxinThe Times of India
- Centre’s top adviser blames States for vaccine shortfallThe Hindu
- Covishield produces more anti-bodies than Covaxin, says studyThe Hindu
Climate talks hit crunch time as Friday deadline loomsLA Times
Currency swap deadline puts N100trn national output at risk — CPPEvanguardngr.com- Covaxin priced at ₹600 for States, ₹1,200 for private hospitalsThe Hindu
- WHO’s approval for Covaxin likely this monthThe Hindu
- Covaxin taken off clinical trial modeThe Hindu
- Oxfam India says Centre’s refusal to renew FCRA registration will hit humanitarian work in 16 StatesThe Hindu
- Full licence for Covaxin may take timeThe Hindu
- DCGI nod for Covaxin human trialsThe Hindu
- Bharat Biotech yet to start supply of May order of Covaxin: CentreThe Hindu
- COVID-19 | AIIMS Delhi starts screening of children for Covaxin trialsThe Hindu
- Can Covaxin booster dose prolong protection?The Hindu
- Covaxin effective against Delta Plus variant: ICMRThe Times of India
- Now, Covaxin on UK’s approved travel listThe Hindu